Target intelligence / Profile preview

Glyceraldehyde 3-phosphate dehydrogenase pseudogene 22 (GAPDHP22)

Target: GAPDHP22
Molecular classification: Other (specifically: Pseudogene)

Overview

Glyceraldehyde 3-phosphate dehydrogenase pseudogene 22 is a processed pseudogene in humans that shares sequence similarity with the protein-coding gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Unlike GAPDH, which encodes a well-known metabolic enzyme involved in glycolysis, GAPDHP22 does not encode a functional protein due to mutations or truncations acquired during evolution. It is not involved in cellular or physiological processes and is not a therapeutic target.

Other names: GAPDHP22Glyceraldehyde-3-phosphate dehydrogenase pseudogene 22

Mechanism of action

None (for the same reason: no protein, no mechanism)

Biological functions

None (as a pseudogene, it lacks biological function; by definition, pseudogenes do not encode functional proteins)

Disease associations

None (pseudogenes generally lack direct disease roles, though some pseudogenes have regulatory functions in rare cases—no such evidence exists for GAPDHP22)

Safety considerations

None (as it is nonfunctional)

Interacting drugs

None (pseudogenes do not produce proteins; drugs cannot interact with them as with functional protein targets)

Biomarkers

None known (there is no evidence suggesting this pseudogene is used as a biomarker for any clinical or research applications)

Beyond the preview

Go deeper on Glyceraldehyde 3-phosphate dehydrogenase pseudogene 22 (GAPDHP22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyceraldehyde 3-phosphate dehydrogenase pseudogene 22 (GAPDHP22).

Explore the full profile